Fundraising Fox

Mathias Falcenberg

Investor

Venture Partner at V-Bio Ventures

Frankfurt Rhine-Main Metropolitan Area

About

Joined V-Bio Ventures as Venture Partner in February 2025. His experience spans healthcare across entrepreneur, investor and corporate roles, including external innovation work at Merck KGaA and venture capital experience at Forbion.

Experience

  1. V-Bio VenturesVenture Partnercurrent2025 — present
  2. Merck HealthcareHead External Innovation Technologies, Scientific Competitive Insights & Externalization2023 — 2025
  3. Merck HealthcareExecutive Director, Head Search & Evaluation Innovative Technologies2022 — 2023
  4. Merck HealthcareSr. Director, Head Search and Evaluation Innovative Technologies2021 — 2022Darmstadt und Umgebung, Deutschland
  5. Merck KGaA, Darmstadt, GermanyDirector, Commercial Lead Bioelectronics; Merck Innovation Center2021Frankfurt am Main, Umgebung
  6. Merck KGaA, Darmstadt, GermanyAssoc. Director, Lead New Business Validation; Merck Innovation Center2020
  7. Merck KGaA, Darmstadt, GermanyAssoc. Director, Innovation Manager; Merck Innovation Center2019 — 2020Darmstadt und Umgebung, Deutschland
  8. Forbion - Impacting the future of medicineAssociate2016 — 2018Munich
  9. Melliax PharmaEntrepreneur / CSO2013 — 2016Martinsried near Munich
  10. Max Planck Institute for BiochemistryProject Leader Metabolic Therapy2009 — 2016Marinsried near Munich
  11. Max Planck Institute for BiochemistryAssociated Scientist2007 — 2009
  12. GSK’s Centre of Excellence for External Drug Discovery & Max Planck Institute for BiochemistryCollaboration Leader2010 — 2012

Education

  1. Max-Planck-Institute of Biochemistry, Department Molecular Biology / TU MunichDoctor of Philosophy (Ph.D.), Biology
  2. Technical University Darmstadt, Department BiochemistryDiploma / Master of Science, Biology2007 — 2011
  3. Technische Universität Darmstadt2002 — 2007

Skills & more

RisikokapitalStart-up-Unternehmen

From Mathias's professional profile.

Same school

Shared employers

Colleagues at V-Bio Ventures